top of page

Annex XVI Products: Product Groups Without a Medical Purpose, Common Specifications and ÜTS Registration

12 hours ago
8 min read
Ek XVI tıbbi amaçlı olmayan ürün grupları ve ÜTS kaydı

SUMMARY

Annex XVI products are product groups to which the Medical Device Regulation (Tıbbi Cihaz Yönetmeliği) applies even though they have no medical intended purpose. Under Article 1 of the Regulation, these products are also called “devices”.

In this article we give, with verbatim quotations from the regulation, the communiqué and the TİTCK ÜTS Registration Guideline TCKKD-KLVZ-03, the Annex XVI list, the common specifications requirement, the transitional provisions of the Communiqué on Annex XVI Common Specifications, and their counterpart in ÜTS registration.

For the ÜTS registration of your Annex XVI devices: Medical Device ÜTS Registration Consultancy

Contents

1. Why Are Annex XVI Products Considered “Devices”?

Article 1 of the Medical Device Regulation:

“(2) For the purposes of this Regulation, medical devices, medical device accessories and the products listed in Annex XVI to which this Regulation applies are hereinafter referred to as “devices”.”

Subparagraph (b) of the third paragraph ties the start of application to the common specifications:

“b) From the date of application of the common specifications adopted under Article 9, taking into account the existing harmonized standards for similar devices with a medical purpose, in particular those based on similar technology, and the latest technological developments, to the product groups without a medical purpose listed in Annex XVI and to the clinical investigations relating to these product groups,”

The definition of “Device” in Article 4 of the ÜTS Registration Guideline also includes the products listed in MDR Annex XVI.

2. The Annex XVI List: Six Product Groups

Annex XVI of the Regulation, “list of groups of products without a medical purpose referred to in the second paragraph of Article 1”:

  • “1. Contact lenses or other items intended to be introduced into or onto the eye.”

  • “2. Products intended to be totally or partially introduced into the human body through surgically invasive means for the purpose of modifying the anatomy or fixation of body parts, with the exception of tattooing products and piercings.”

  • “3. Substances, combinations of substances, or items intended to be used for facial or other dermal or mucous membrane filling by subcutaneous, submucous or intradermal injection or other introduction, excluding those for tattooing.”

  • “4. Equipment intended to be used to reduce, remove or destroy adipose tissue, such as equipment for liposuction, lipolysis or lipoplasty.”

  • “5. High intensity electromagnetic radiation (e.g. infra-red, visible light and ultra-violet) emitting equipment intended for use on the human body, including coherent and non-coherent sources, monochromatic and broad spectrum, such as lasers and intense pulsed light equipment, for skin resurfacing, tattoo removal, hair removal or other skin treatment.”

  • “6. Brain stimulation equipment that applies electrical currents or magnetic or electromagnetic fields that penetrate the cranium to modify neuronal activity in the brain.”

The list contains two exclusions: tattooing products and piercings in group 2, and those intended for tattooing in group 3, are out of scope. For the product groups, see our pages on dermal filler ÜTS registration, laser hair removal device ÜTS registration and contact lens ÜTS registration.

3. The Common Specifications Requirement: Article 9

The general rule is in the third paragraph:

“(3) Manufacturers comply with the common specifications referred to in the first paragraph unless they can duly justify that they have adopted solutions that ensure a level of safety and performance at least equivalent to them.”

For Annex XVI products, the fourth and fifth paragraphs:

“(4) Manufacturers of the products listed in Annex XVI comply, notwithstanding the third paragraph, with the relevant common specifications for these products.”

“(5) The common specifications for each product group listed in Annex XVI address, at a minimum, the application of risk management as set out in Annex I for the product groups concerned and, where necessary, the clinical evaluation regarding safety.”

The fourth paragraph uses the phrase “notwithstanding the third paragraph”; the equivalent-solution justification in the third paragraph does not apply to Annex XVI products. For the concept, see our page on what are common specifications.

4. Both Medical and Non-Medical Intended Purpose

“(6) Where a device has both a medical and a non-medical intended purpose, these devices cumulatively meet the requirements applicable to devices with a medical intended purpose and the requirements applicable to devices without a medical intended purpose.”

Point 9 of Annex I also sets out the meaning of the safety requirement for Annex XVI devices:

“9. For the devices referred to in Annex XVI, the general safety requirements set out in points 1 and 8 of this Annex mean that the device, when used under the conditions and for the purposes intended, presents no risk at all or presents a risk that is no more than the maximum acceptable risk related to the use of the product, consistent with a high level of protection of the safety and health of persons.”

5. Clinical Evaluation: Performance Instead of Clinical Benefit

Article 61 of the Regulation:

“(8) In the case of products listed in Annex XVI that have no medical intended purpose, the requirement to demonstrate a clinical benefit under this Part and Annex XIV and Annex XV is understood as a requirement to demonstrate the performance of the device.”

According to Part A of Annex VI, the registration information also includes the following item for Annex XVI devices:

“2.12. In the case of devices listed in Annex XVI, a statement that the intended purpose of the device is other than a medical purpose,”

For clinical evaluation, see our article on clinical evaluation and PMCF.

6. The Communiqué on Annex XVI Common Specifications

The common specifications are set by the “Communiqué on the Determination of Common Specifications for the Product Groups Without a Medical Purpose Listed in Annex XVI of the Medical Device Regulation” (Tıbbi Cihaz Yönetmeliğinin Ek XVI’sında Listelenen Tıbbi Amaçlı Olmayan Ürün Gruplarına Yönelik Ortak Spesifikasyonların Belirlenmesi Hakkında Tebliğ). Under Article 7 of the Communiqué, it enters into force on its date of publication, with effect from 22/6/2023.

“ARTICLE 2- (1) This Communiqué applies to all the product groups without a medical purpose listed in Annex XVI of the Medical Device Regulation.”

“ARTICLE 5- (1) The common specifications set out in Annex I apply to all of the product groups without a medical purpose.”

Under Article 5 of the Communiqué, Annex II applies to contact lenses, Annex III to products intended to modify the anatomy, Annex IV to dermal fillers, Annex V to equipment for reducing adipose tissue, Annex VI to equipment emitting high intensity electromagnetic radiation, and Annex VII to brain stimulation equipment. Under Article 6, the Communiqué was prepared taking into account Commission Implementing Regulations (EU) 2022/2346 and (EU) 2023/1194.

7. Transitional Provisions

Provisional Article 1 of the Regulation:

“(13) Until the date of application referred to for the relevant common specifications for the product group listed in Annex XVI, the rules on the qualification of the said products as medical devices under the Medical Device Regulation repealed by Article 110 continue to apply.”

“(14) The common specifications required for the product group listed in Annex XVI of this Regulation start to apply 6 months after the date on which these specifications enter into force.”

Provisional Article 1 of the Communiqué requires two conditions for products for which a notified body must be involved in the conformity assessment:

  • “a) That the product is already lawfully marketed before 22/6/2023 and continues to comply, before 22/6/2023, with the requirements of the national legislation applicable to the product,”

  • “b) That there is no significant change in the design and intended purpose of the product,”

Under these conditions, a product for which a clinical investigation is designed or conducted may be placed on the market or put into service until 31/12/2029, and a product for which no clinical investigation is intended until 31/12/2028. The second, third, fourth and sixth paragraphs of the same article regulate the intermediate conditions of these periods, such as notification of the clinical investigation, commencement of the clinical investigation and signing a written agreement with a notified body.

8. Sales and Advertising: Products That Can Be Sold Outside a Sales Center

Annex-3 of the Regulation on Medical Device Sales, Advertising and Promotion (Tıbbi Cihaz Satış, Reklam ve Tanıtım Yönetmeliği) (List of Devices That Can Be Sold Outside Sales Centers) lists Annex XVI products in item 16:

“Excluding those whose points of sale are restricted under their relevant legislation and those manufactured exclusively for use by healthcare professionals, the products within the scope of “Annex XVI - List of Groups of Products Without a Medical Purpose Referred to in the Second Paragraph of Article 1”, annexed to the Medical Device Regulation published in the Official Gazette No. 31499 (repeated) dated 2/6/2021.”

Under the second paragraph of Article 33 of the Regulation, an authorization certificate is not required for the places where the devices in Annex-3 are sold, except for their manufacturer or importer; this exception does not remove obligations under other relevant legislation. Under Article 15, devices in Annex-3 may be advertised freely to consumers. For the advertising rules, see our article on medical device advertising and promotion rules.

9. Annex XVI Products in ÜTS Registration

The field “Tıbbi Cihaz Satış, Reklam ve Tanıtım Yönetmeliği Ek-3 Kapsamında mı?” (Is it within the scope of Annex-3 of the Regulation on Medical Device Sales, Advertising and Promotion?) in the seventh paragraph of Article 27 of the ÜTS Registration Guideline:

“2) This field is selected as “Evet” (Yes) if the device concerned is among the products within the scope of Annex-3 of the Regulation on Medical Device Sales, Advertising and Promotion published in the Official Gazette No. 29001 dated 15/5/2014, and as “Hayır” (No) if it is not among the products within the scope of Annex-3 of the said Regulation.”

In the same subparagraph, the guideline lists the current Annex-3 list and, in the last item, shows the products in the MDR Annex XVI list excluding those whose points of sale are restricted and those manufactured exclusively for use by healthcare professionals. Under Article 4 of the guideline, Annex XVI products are within the definition of “device” in ÜTS, and this field is regulated in Article 27, which governs device registration under the MDR. For product registration in general, see our article on ÜTS product registration.

10. Frequently Asked Questions

Why is a product with no medical purpose subject to the medical device legislation?

The second paragraph of Article 1 of the Medical Device Regulation also calls the products listed in Annex XVI “devices”; under the third paragraph, the Regulation applies to these product groups from the date of application of the common specifications.

Are IPL and laser hair removal equipment in Annex XVI?

Yes. Item 5 of Annex XVI lists lasers and intense pulsed light (IPL) equipment for hair removal and other skin treatments.

Are tattooing products within the scope of Annex XVI?

No. Item 2 of Annex XVI leaves tattooing products and piercings out of scope, and item 3 leaves out those intended for tattooing.

Is it mandatory to comply with the common specifications for Annex XVI products?

Yes. Under the fourth paragraph of Article 9, manufacturers of Annex XVI products comply with the relevant common specifications notwithstanding the third paragraph.

Which rules apply if the device has both a medical and an aesthetic purpose?

Under the sixth paragraph of Article 9, the device cumulatively meets the requirements applicable to the medical and non-medical intended purposes.

For the ÜTS registration of your Annex XVI devices: Medical Device ÜTS Registration Consultancy

Sources

 
 

Medical Device ÜTS Registration Consultancy

Request an ÜTS registration consultancy quote

Ehlibeyt Mahallesi, Tekstilciler Caddesi No: 35/7 06520 Çankaya / Ankara - TÜRKİYE

Cevizli Mahallesi, Zuhal Caddesi Ritim İstanbul B Blok, No:44 Maltepe / İstanbul - TÜRKİYE

info@medexmedikal.com
+90 505 580 4622
+90 312 389 1354

ÜTS Guides · Legislation Calendar · Glossary · ÜTS Guide Index · Frequently Asked Questions

Services: ÜTS Consultancy · Who Carries Out the ÜTS Registration? · ÜTS Document Registration Consultancy · ÜTS Product Registration Consultancy · Importer ÜTS Registration Consultancy · Sales Centre Authorisation Certificate · EUDAMED Registration Consultancy · MDR/IVDR Declaration of Conformity · Technical File Preliminary Review · Label and Instructions for Use Check · PRRC Service · PMS and PSUR · Clinical Evaluation · EMDN and GMDN Code Determination · Certificate of Free Sale · EUDAMED XML Generator · ÜTS Registration Training · Correction of a Rejected ÜTS Application

KVKK and Privacy Policy | Cookie Policy | Accessibility Statement

© 2026 Medex Kurumsal Danışmanlık Ltd. Şti.

bottom of page
WhatsApp Hemen Ara